Results 231 to 240 of about 14,780 (257)
Some of the next articles are maybe not open access.

Effects of fucoidan on gut flora and tumor prevention in 1,2-dimethylhydrazine-induced colorectal carcinogenesis.

Journal of Nutritional Biochemistry, 2020
Colorectal cancer (CRC) is one of the major malignancies in humans. This study was designed to evaluate the effects of fucoidan on gut flora and tumor prevention in 1,2-dimethylhydrazine-induced colorectal carcinogenesis in rats.
Meilan Xue   +6 more
semanticscholar   +3 more sources

Encapsulation and delivery of phage as a novel method for gut flora manipulation in situ: A review.

Journal of Controlled Release, 2022
Intestinal flora regulation is an effective method to intervene and treat diseases associated with microbiome imbalance. In addition to conventional probiotic supplement, phage delivery has recently exhibited great prospect in modifying gut flora ...
Yufan Yang   +9 more
semanticscholar   +1 more source

ROS Scavenging and Inflammation-directed Polydopamine Nanoparticles Regulate Gut Immunity and Flora Therapy in Inflammatory Bowel Disease.

Acta Biomaterialia, 2023
Dysfunction of the intestinal mucosal immune system and dysbiosis of the intestinal microflora can induce inflammatory bowel disease. However, drug-mediated clinical treatment remains a challenge due to its poor therapeutic efficacy and severe side ...
Meiyu Bao   +14 more
semanticscholar   +1 more source

Fermented noni (Morinda citrifolia L.) fruit juice improved oxidative stress and insulin resistance under the synergistic effect of Nrf2/ARE pathway and gut flora in db/db mice and HepG2 cells.

Food & Function, 2022
Oxidative stress interferes with blood glucose homeostasis, leading to insulin resistance (IR) and hyperglycemia, which eventually induce type 2 diabetes (T2DM).
Xuguang Zhang   +5 more
semanticscholar   +1 more source

Gut flora and metabolism are altered in epilepsy and partially restored after ketogenic diets.

Microbial Pathogenesis, 2021
OBJECTIVE The aim of this study was to investigate the composition of the intestinal microbiota and its association with fecal short chain fatty acids (SCFAs) in children with drug refractory epilepsy (DRE) before and after treatment with a ketogenic ...
Xue Gong   +7 more
semanticscholar   +1 more source

Safety Assessment on the Safety and Efficacy of an Additive of Bacillus Velezensis as the Active Agent (Enviva® PRO 202 GT) Used as a Feed Additive for Turkeys for Fattening and Turkeys Reared for Breeding (RP1258)

FSA Research and Evidence
An application was submitted to the Food Standards Agency in September 2021 from Genencor International B.V, (‘the applicant’) for the new use application (extension of species) of an additive (Enviva® PRO 202 GT) containing Bacillus amyloliquefaciens ...

semanticscholar   +1 more source

Safety Assessment on the Safety and Efficacy of an Additive Consisting of Bacillus Velezensis ATCC PTA-6737 (PB6) Used as a Feed Additive for Use in Turkeys for Fattening, Turkeys Reared for Breeding and All Growing Poultry (RP1696)

FSA Research and Evidence
An application was submitted to the Food Standards Agency in September 2022 from Kemin Europa N.V. (‘the applicant’), for the renewal and modification of an additive consisting of Bacillus velezensis ATCC PTA-6737 (PB6), under the category ‘zootechnical ...

semanticscholar   +1 more source

Safety Assessment on the Safety and Efficacy of Bacillus Velezensis ATCC PTA-6737 (PB6) as a Feed Additive for Weaned Piglets, Weaned Minor Porcine Species, Sows and All Pig species. (RP1512)

FSA Research and Evidence
An application was submitted to the Food Standards Agency (FSA) and Food Standards Scotland (FSS) in April 2022 from Kemin Europa N.V. (‘the applicant’) for the renewal and new use (extension of species) to all pig species of an additive containing ...

semanticscholar   +1 more source

Assessment on the Safety and Efficacy of a Feed Additive Consisting of Bacillus ⁠subtilis DSM 32324, Bacillus ⁠subtilis DSM 32325 and Bacillus ⁠amyloliquefaciens DSM 25840 (GalliPro® Fit & GalliPro® Fit 10) for All Poultry (Chr. Hansen A/S)(RP2245)

FSA Research and Evidence
An application was submitted to the Food Standards Agency and Food Standards Scotland in January 2024 from Chr. Hansen A/S (“the applicant”) for the authorisation of an additive consisting of Bacillus subtilis DSM 32324, Bacillus subtilis DSM 32325

semanticscholar   +1 more source

Home - About - Disclaimer - Privacy